The use of an oral prostaglandin inhibitor following splintage in fractures of the distal radius--a prospective trial.

Abstract	A prospective, double-blind, controlled trial is reported in which oral diclofenac, a prostaglandin inhibitor, was given for 1 week immediately following the removal of splintage for fracture of the distal end of the radius. The patients who received the prostaglandin inhibitor had less pain, a more rapid recovery of range of movement and a stronger grip than those who received a placebo.
Authors	A P Thomas, S Brooks
Journal	Injury (Injury) Vol. 17 Issue 3 Pg. 179-81 (May 1986) ISSN: 0020-1383 [Print] Netherlands
PMID	3546124 (Publication Type: Clinical Trial, Controlled Clinical Trial, Journal Article)
Chemical References	Diclofenac
Topics	Adolescent Adult Aged Clinical Trials as Topic Diclofenac (adverse effects, therapeutic use) Double-Blind Method Female Humans Male Middle Aged Prospective Studies Radius Fractures (drug therapy, therapy) Splints

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!